Reduce Torrent Pharma; target of Rs 2500: Dolat Capital

Reduce Torrent Pharma; target of Rs 2500: Dolat Capital
Reduce Torrent Pharma; target of Rs 2500: Dolat Capital Dolat Capital recommended reduce rating on Torrent Pharma with a target price of Rs 2500 in its research report dated July 30, 2020.